United States: GSK v. Teva: The Skinny On Induced Infringement And Label Carve-Outs - Kilpatrick Townsend & Stockton LLP

Section viii of the Hatch-Waxman Act permits an Abbreviated New Drug Application (ANDA) applicant to obtain FDA approval to market a generic version of a drug for a non-patented use...